User:Blent/Seminar 07 fall: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 29: Line 29:
** [http://en.wikipedia.org/wiki/Carbamazepine Carbamazepine] is an long half-live drug
** [http://en.wikipedia.org/wiki/Carbamazepine Carbamazepine] is an long half-live drug
* case study: Warfarin (抗凝血劑) and dosage estimation
* case study: Warfarin (抗凝血劑) and dosage estimation
** [http://www.aafp.org/afp/990201ap/635.html Warfarin Therapy: Evolving Strategies in Anticoagulation, 1999 American Family Physician]
** [http://genome.wellcome.ac.uk/doc_WTD020935.html  Genetic variation (VKORC1) alters response to warfarin, 2/6/05. By NIH/National Institute of General Medical Sciences]
* case study: Diabetes and Diagnosis
* case study: Diabetes and Diagnosis
* BioBank and Biomarkers discovery
* BioBank and Biomarkers discovery

Revision as of 22:42, 29 September 2007

Title

  • Toward Personalized Medicine in BMI-based Methodology: A case study of Carbamazepine and challenges in the future

Outlines (Sep 27, 2007)

Outlines (Sep 20, 2007)

  • BMI = BI + MI
    • what BMI can do
      • Neuroinformatics (NI)
      • Cancer research (CR)
  • Personalized Medicine (PM)

Background

Materials

Notes